SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
---|---|---|---|---|---|---|---|---|---|
18-Nov-24 8:37 PM View: | Masson Elizabeth EVP | Cormedix Inc. (CRMD) | 14-Nov-24 | Option Exercise | 140,027 | $4.48 | $627,727.00 | 61% 230.82K to 370.85K | 8% |
18-Nov-24 8:37 PM View: | Masson Elizabeth EVP | Cormedix Inc. (CRMD) | 14-Nov-24 | Private Option Sale | 140,027 | $11.18 | $1,565,670.00 | (38%) 370.85K to 230.82K | |
13-May-24 4:22 PM View: | Todisco Joseph Chief Executive Officer Director | Cormedix Inc. (CRMD) | 10-May-24 | Payment of Exercise | 26,982 | $5.17 | $139,497.00 | (8%) 352.84K to 325.86K | |
14-Mar-24 8:45 AM View: | Todisco Joseph Chief Executive Officer Director | Cormedix Inc. (CRMD) | 13-Mar-24 | Private Purchase | 13,561 | $3.74 | $50,718.10 | 4% 339.28K to 352.84K | |
17-Jan-24 8:10 PM View: | David Matthew T Chief Financial Officer | Cormedix Inc. (CRMD) | 12-Jan-24 | Payment of Exercise | 5,216 | $3.47 | $18,099.50 | (10%) 53.15K to 47.93K | |
17-Jan-24 8:11 PM View: | Masson Elizabeth EVP, Head of Clinical Ops. | Cormedix Inc. (CRMD) | 12-Jan-24 | Grant | 50,000 | -- | -- | 625% 8.0K to 58.0K | |
17-Jan-24 8:04 PM View: | Todisco Joseph Chief Executive Officer Director | Cormedix Inc. (CRMD) | 12-Jan-24 | Grant | 133,333 | -- | -- | 61% 219.73K to 353.06K | |
17-Jan-24 8:09 PM View: | Mistry Erin Chief Commercial Officer | Cormedix Inc. (CRMD) | 12-Jan-24 | Grant | 50,000 | -- | -- | 1020% 4.9K to 54.9K | |
17-Jan-24 8:11 PM View: | Masson Elizabeth EVP, Head of Clinical Ops. | Cormedix Inc. (CRMD) | 12-Jan-24 | Payment of Exercise | 4,603 | $3.47 | $15,972.40 | (8%) 58.0K to 53.4K | |
17-Jan-24 8:04 PM View: | Todisco Joseph Chief Executive Officer Director | Cormedix Inc. (CRMD) | 12-Jan-24 | Payment of Exercise | 13,781 | $3.47 | $47,820.10 | (4%) 353.06K to 339.28K | |
17-Jan-24 8:10 PM View: | David Matthew T Chief Financial Officer | Cormedix Inc. (CRMD) | 12-Jan-24 | Grant | 50,000 | -- | -- | 1587% 3.15K to 53.15K | |
17-Jan-24 8:09 PM View: | Mistry Erin Chief Commercial Officer | Cormedix Inc. (CRMD) | 12-Jan-24 | Payment of Exercise | 4,389 | $3.47 | $15,229.80 | (8%) 54.9K to 50.51K | |
18-Dec-23 4:47 PM View: | Dunton Alan W Director | Cormedix Inc. (CRMD) | 15-Dec-23 | Purchase | 3,000 | $3.30 | $9,900.00 | 24% 12.25K to 15.25K | |
18-Dec-23 4:47 PM View: | Dunton Alan W Director | Cormedix Inc. (CRMD) | 14-Dec-23 | Private Purchase | 3,000 | $3.45 | $10,350.00 | 32% 9.25K to 12.25K | |
14-Dec-23 4:05 PM View: | Zelnick Kaufman Beth Chief Legal Officer | Cormedix Inc. (CRMD) | 12-Dec-23 | Grant | 50,000 | -- | -- | 100% 0 to 50.0K | |
21-Nov-23 4:00 PM View: | Mistry Erin Chief Commercial Officer | Cormedix Inc. (CRMD) | 17-Nov-23 | Private Purchase | 1,000 | $4.00 | $4,000.00 | 26% 3.9K to 4.9K | |
17-Nov-23 4:50 PM View: | Lefkowitz Steven W Director | Cormedix Inc. (CRMD) | 16-Nov-23 | Option Exercise | 15,000 | $2.25 | $33,750.00 | 16% 92.65K to 107.65K | |
08-Sep-23 4:21 PM View: | Todisco Joseph Chief Executive Officer Director | Cormedix Inc. (CRMD) | 08-Sep-23 | Private Purchase | 10,000 | $3.71 | $37,100.00 | 5% 209.73K to 219.73K | |
19-May-23 4:02 PM View: | Kaplan Myron Director | Cormedix Inc. (CRMD) | 18-May-23 | Market Purchase | 6,000 | $4.54 | $27,258.00 | 3% 190.03K to 196.03K | 6% |
17-May-23 5:35 PM View: | Todisco Joseph Chief Executive Officer Director | Cormedix Inc. (CRMD) | 17-May-23 | Grant | 5,000 | $4.58 | $22,900.00 | 2% 204.73K to 209.73K | 5% |
17-May-23 7:08 PM View: | Dunton Alan W Director | Cormedix Inc. (CRMD) | 17-May-23 | Grant | 3,000 | $4.33 | $12,979.80 | 48% 6.25K to 9.25K | |
17-May-23 5:37 PM View: | Stewart Robert A Director | Cormedix Inc. (CRMD) | 17-May-23 | Grant | 10,000 | $4.37 | $43,735.00 | 1000% 1.0K to 11.0K | |
17-May-23 7:25 PM View: | Costa Paulo F Director | Cormedix Inc. (CRMD) | 17-May-23 | Grant | 10,000 | $4.65 | $46,500.00 | 100% 0 to 10.0K | 4% |
12-May-23 6:16 PM View: | Todisco Joseph Chief Executive Officer Director | Cormedix Inc. (CRMD) | 10-May-23 | Payment of Exercise | 37,443 | $5.30 | $198,448.00 | (15%) 242.17K to 204.73K | |
16-Nov-22 4:56 PM View: | Todisco Joseph Chief Executive Officer Director | Cormedix Inc. (CRMD) | 15-Nov-22 | Private Purchase | 20,000 | $3.82 | $76,400.00 | 9% 222.17K to 242.17K | |
25-Aug-22 8:37 AM View: | Todisco Joseph Chief Executive Officer Director | Cormedix Inc. (CRMD) | 24-Aug-22 | Private Purchase | 4,700 | $3.92 | $18,424.00 | 2% 217.47K to 222.17K | |
18-May-22 5:21 PM View: | Kaplan Myron Director | Cormedix Inc. (CRMD) | 17-May-22 | Private Purchase | 5,000 | $3.78 | $18,900.00 | 3% 185.03K to 190.03K | |
17-May-22 8:30 AM View: | Todisco Joseph Chief Executive Officer Director | Cormedix Inc. (CRMD) | 16-May-22 | Private Purchase | 10,000 | $3.38 | $33,800.00 | 2% 414.94K to 424.94K | |
12-May-22 4:30 PM View: | Todisco Joseph Chief Executive Officer Director | Cormedix Inc. (CRMD) | 10-May-22 | Grant | 207,469 | -- | -- | 100% 0 to 207.47K | |
29-Dec-21 4:08 PM View: | Kaplan Myron Director | Cormedix Inc. (CRMD) | 27-Dec-21 | Gift | 35,000 | -- | -- | (20%) 175.03K to 140.03K | |
07-Dec-21 6:44 PM View: | David Matthew T Interim CEO and CFO | Cormedix Inc. (CRMD) | 06-Dec-21 | Market Purchase Duplicate | 1,000 | $4.50 | $4,500.00 | 47% 2.15K to 3.15K | 3% |
07-Dec-21 6:44 PM View: | David Matthew T Interim CEO and CFO | Cormedix Inc. (CRMD) | 06-Dec-21 | Market Purchase | 1,000 | $4.50 | $4,500.00 | 47% 2.15K to 3.15K | 3% |
19-Nov-21 9:53 AM View: | David Matthew T Interim CEO and CFO | Cormedix Inc. (CRMD) | 17-Nov-21 | Market Purchase | 1,000 | $5.07 | $5,070.00 | 87% 1.15K to 2.15K | (2%) |
19-Nov-21 4:45 PM View: | Kaplan Myron Director | Cormedix Inc. (CRMD) | 16-Nov-21 | Market Purchase | 10,000 | $5.14 | $51,400.00 | 6% 165.03K to 175.03K | (4%) |
25-May-21 4:46 PM View: | Masson Elizabeth EVP, Head of Clinical Ops | Cormedix Inc. (CRMD) | 21-May-21 | Market Sale | 8,000 | $6.92 | $55,393.60 | (100%) 8.0K to 0 | (< 1%) |
19-May-21 5:40 PM View: | Kaplan Myron Director | Cormedix Inc. (CRMD) | 17-May-21 | Market Purchase | 15,000 | $6.03 | $90,477.00 | 10% 150.03K to 165.03K | |
09-Sep-20 8:47 AM View: | Lefkowitz Steven W Director | Cormedix Inc. (CRMD) | 04-Sep-20 | Market Purchase | 5,715 | $3.99 | $22,815.70 | 7% 86.94K to 92.65K | |
08-Sep-20 8:38 AM View: | David Matthew T Chief Financial Officer | Cormedix Inc. (CRMD) | 03-Sep-20 | Market Purchase | 1,150 | $4.07 | $4,680.50 | 100% 0 to 1.15K | |
04-Sep-20 8:25 AM View: | Kaplan Myron Director | Cormedix Inc. (CRMD) | 02-Sep-20 | Market Purchase | 15,300 | $4.27 | $65,358.50 | 11% 134.73K to 150.03K | |
20-Aug-20 5:53 PM View: | Khan Mehmood Director | Cormedix Inc. (CRMD) | 19-Aug-20 | Market Purchase | 17,837 | $4.90 | $87,472.00 | 11% 160.93K to 178.77K | |
20-Aug-20 5:53 PM View: | Khan Mehmood Director | Cormedix Inc. (CRMD) | 18-Aug-20 | Market Purchase | 27,913 | $4.80 | $133,878.00 | 21% 133.02K to 160.93K | |
17-Aug-20 8:06 PM View: | Armstrong John L Jr Exec VP of Tech Operations | Cormedix Inc. (CRMD) | 14-Aug-20 | Market Purchase | 27,500 | $4.22 | $116,110.00 | 40% 69.38K to 96.88K | |
17-Aug-20 6:45 PM View: | Baluch Khoso Chief Executive Officer Director | Cormedix Inc. (CRMD) | 13-Aug-20 | Market Purchase | 4,830 | $4.14 | $19,985.10 | 9% 56.08K to 60.91K | |
17-Aug-20 7:08 PM View: | Mounts Phoebe General Counsel | Cormedix Inc. (CRMD) | 13-Aug-20 | Market Purchase | 2,525 | $4.03 | $10,175.80 | 54% 4.67K to 7.2K | |
17-Aug-20 7:02 PM View: | Kaplan Myron Director | Cormedix Inc. (CRMD) | 13-Aug-20 | Market Purchase | 15,000 | $4.08 | $61,159.50 | 13% 119.73K to 134.73K | |
14-Aug-20 5:29 PM View: | Dunton Alan W Director | Cormedix Inc. (CRMD) | 12-Aug-20 | Market Purchase | 5,000 | $3.95 | $19,750.00 | 400% 1.25K to 6.25K | |
18-May-20 4:20 PM View: | Kaplan Myron Director | Cormedix Inc. (CRMD) | 15-May-20 | Market Purchase | 10,000 | $3.85 | $38,500.00 | 9% 109.73K to 119.73K | |
18-Mar-20 4:25 PM View: | Baluch Khoso Chief Executive Officer Director | Cormedix Inc. (CRMD) | 18-Mar-20 | Market Purchase | 3,500 | $2.61 | $9,135.00 | 7% 52.58K to 56.08K | |
19-Mar-20 4:18 PM View: | Mounts Phoebe General Counsel | Cormedix Inc. (CRMD) | 18-Mar-20 | Market Purchase | 3,250 | $3.05 | $9,912.50 | 228% 1.43K to 4.67K | |
27-Feb-20 9:48 PM View: | Lefkowitz Steven W Director | Cormedix Inc. (CRMD) | 07-Jan-20 | Exercise (in-the money or at-the-money) | 3,000 | $4.50 | $13,500.00 | 3% 88.93K to 91.93K |